So few patients have taken advantage of advances in hand transplantation technology that some medical centers have yet to perform their first procedure two years after launching programs. Costs, patient selection criteria and the prospect of lifelong treatment with immunosuppressants deter possible candidates, experts say. Researchers are seeking ways to prevent organ rejection that use fewer drugs.

Related Summaries